Immunogenicity of COVID ‐19 vaccines in patients with follicular lymphoma receiving frontline chemoimmunotherapy
Summary: Immune responses to primary COVID‐19 vaccination were investigated in 58 patients with follicular lymphoma (FL) as part of the PETReA trial of frontline therapy (EudraCT 2016–004010‐10). COVID‐19 vaccines (BNT162b2 or ChAdOx1) were administered before, during or after cytoreductive treatmen...
Главные авторы: | Lim, YJ, Ward, V, Brown, A, Phillips, E, Kronsteiner, B, Malone, T, Jennings, D, Healy, S, Longet, S, James, T, Thomson, P, Farrell, L, Oates, M, Jackson, R, Morrison, A, Burns, M, Carroll, M, Klenerman, P, Turtle, L, Naisbitt, D, Rhodes, M, Robinson, K, Gatto, S, Young, M, Eyre, TA, Eyre, DW, Dunachie, S, Barnes, E |
---|---|
Формат: | Journal article |
Язык: | English |
Опубликовано: |
Wiley
2024
|
Схожие документы
-
Survival in elderly follicular lymphoma patients who receive frontline chemo-immunotherapy.
по: Griffiths, R, и др.
Опубликовано: (2010) -
Letter: Chemoimmunotherapy of adult acute leukaemia.
по: Peto, R, и др.
Опубликовано: (1975) -
BNIP3 expression in follicular lymphoma.
по: Sington, J, и др.
Опубликовано: (2007) -
A model for effects of adaptive immunity on tumor response to chemotherapy and chemoimmunotherapy.
по: Robertson-Tessi, M, и др.
Опубликовано: (2015) -
Results of a multicentre UK-wide compassionate use programme evaluating the efficacy of idelalisib monotherapy in relapsed, refractory follicular lymphoma.
по: Eyre, T, и др.
Опубликовано: (2017)